Metraipolis › archive › dc_85b3512ec1cf
Real-world effectiveness of high-efficacy therapies in multiple sclerosis: a propensity score-matched cohort study — Europe PMC PMID:41908274
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41908274
- DOI
- 10.3389/fneur.2026.1773074
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T10:24:26.942Z
- SHA-256 of the archived text
a7315a77964196a49d29d7ae605bd47102c51ac56d35c04244eecb91325afad7- Stable URL of this page
https://metraipolis.com/documento/dc_85b3512ec1cf
How to cite
Real-world effectiveness of high-efficacy therapies in multiple sclerosis: a propensity score-matched cohort study — Europe PMC PMID:41908274 — Europe PMC (en), https://europepmc.org/article/MED/41908274 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85b3512ec1cf (Metraipolis archive dc_85b3512ec1cf, sha256 a7315a77964196a49d29d7ae605bd47102c51ac56d35c04244eecb91325afad7)
BibTeX
@misc{dc85b3512ec1cf,
title = {Real-world effectiveness of high-efficacy therapies in multiple sclerosis: a propensity score-matched cohort study — Europe PMC PMID:41908274},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41908274},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85b3512ec1cf; sha256 a7315a77964196a49d29d7ae605bd47102c51ac56d35c04244eecb91325afad7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41908274. Agents can read the archived copy with the MCP tool read_document.